Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
Top

01-01-2015 | Renal cell carcinoma | Article

13. The Role of Radiation Therapy in Renal Cell Carcinoma

Authors: Jonathan Verma, MD, Anita Mahajan, MD

Publisher: Springer International Publishing

Login to get access

Abstract

Although renal cell carcinoma (RCC) is traditionally considered to be a radio-resistant neoplasm, there is in vitro and clinical evidence that it does respond to radiation therapy (RT). There are both retrospective and randomized data in the literature describing outcomes and toxicity of RT in the adjuvant setting and for distant metastases. In general, the available randomized trials have found that RT in the adjuvant setting does not provide any survival benefit and is associated with unacceptable toxicity. Retrospective data suggest that radiation in the form of whole-brain radiotherapy or stereotactic radiosurgery can provide symptomatic relief and local control of brain metastases. In addition, RT has been found to be effective in palliation for symptomatic bone metastases. In this chapter, we review the methods of RT delivery and the relevant evidence regarding its role in the treatment of RCC and conclude that RT does not have a major role in the management of localized RCC in the adjuvant setting but is effective for palliation and local control of distant sites of metastasis to the bone and brain in particular.
Literature
1.
Deschavanne PJ, Fertil B (1996) A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 34(1):251–266PubMedCrossRef
2.
Otto U et al (1985) Transplantation of human renal cell carcinoma into NMRI nu/nu mice. III. Effect of irradiation on tumor acceptance and tumor growth. J Urol 134(1):170–174PubMed
3.
Chiou RK et al (1988) Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model. Cancer 61(9):1766–1775PubMedCrossRef
4.
Halperin EC, Harisiadis L (1983) The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51(4):614–617PubMedCrossRef
5.
Onufrey V, Mohiuddin M (1985) Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 11(11):2007–2009PubMedCrossRef
6.
Chang EL et al (2007) Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151–160PubMedCrossRef
7.
Windeyer B, Riches E (1964) Radiotherapy and combined treatment in adults. In: Riches EW (ed) Tumours of the kidney and ureter. E & S Livingstone Ltd, Edinburgh
8.
Nias AH (1967) Radiobiological aspects of pre-operative irradiation. Br J Radiol 40(471):166–169PubMedCrossRef
9.
Flocks RH, Kadesky MC (1958) Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. J Urol 79(2):196–201PubMed
10.
van der Werf-Messing B (1973) Proceedings: carcinoma of the kidney. Cancer 32(5):1056–1061PubMedCrossRef
11.
Juusela H et al (1977) Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 11(3):277–281PubMedCrossRef
12.
van der Werf-Messing B, van der Heul RO, Ledeboer RC (1981) Renal cell carcinoma trial. Strahlenther Sonderb 76:169–175
13.
Riches EW, Griffiths IH, Thackray AC (1951) New growths of the kidney and ureter. Br J Urol 23(4):297–356PubMedCrossRef
14.
Bratherton DG (1964) Tumours of the kidneys and suprarenals. III. The place of radiotherapy in the treatment of hypernephroma. Br J Radiol 37:141–146PubMedCrossRef
15.
Rafla S (1970) Renal cell carcinoma. Natural history and results of treatment. Cancer 25(1):26–40PubMedCrossRef
16.
Finney R (1973) The value of radiotherapy in the treatment of hypernephroma–a clinical trial. Br J Urol 45(3):258–269PubMedCrossRef
17.
Kjaer M, Frederiksen PL, Engelholm SA (1987) Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group. Int J Radiat Oncol Biol Phys 13(5):665–672PubMedCrossRef
18.
Rabinovitch RA et al (1994) Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol: Off J Am Soc Clin Oncol 12(1):206–212
19.
Stein M et al (1992) The value of postoperative irradiation in renal cell cancer. Radiother Oncol: J Eur Soc Ther Radiol Oncol 24(1):41–44CrossRef
20.
Makarewicz R et al (1998) The value of postoperative radiotherapy in advanced renal cell cancer. Neoplasma 45(6):380–383PubMed
21.
Kao GD et al (1994) Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy planned with CT. Radiology 193(3):725–730PubMedCrossRef
22.
Gez E et al (2002) Postoperative irradiation in localized renal cell carcinoma: the Rambam Medical Center experience. Tumori 88(6):500–502PubMed
23.
Tunio MA, Hashmi A, Rafi M (2010) Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol: Off J Eur Soc Med Oncol/ESMO 21(9):1839–1845CrossRef
24.
Walsh L et al (2006) Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol 50(4):795–800, discussion 800PubMedCrossRef
25.
Beitler JJ et al (2004) Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol 27(6):646–648PubMedCrossRef
26.
Wersall PJ et al (2005) Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol: J Eur Soc Ther Radiol Oncol 77(1):88–95CrossRef
27.
Lo CH et al (2014) Novel application of stereotactic ablative radiotherapy using CyberKnife for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences. Oncol Lett 8(1): p. 355–360
28.
Nair VJ et al (2013) CyberKnife for inoperable renal tumors: Canadian pioneering experience. Can J Urol 20(5): p. 6944–6949
29.
Gay PC, Litchy WJ, Cascino TL (1987) Brain metastasis in hypernephroma. J Neurooncol 5(1):51–56PubMedCrossRef
30.
Nieder C, Niewald M, Schnabel K (1996) Treatment of brain metastases from hypernephroma. Urol Int 57(1):17–20PubMedCrossRef
31.
Cairncross JG, Kim JH, Posner JB (1980) Radiation therapy for brain metastases. Ann Neurol 7(6):529–541PubMedCrossRef
32.
Zimm S et al (1981) Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48(2):384–394PubMedCrossRef
33.
Wronski M et al (1997) External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 37(4):753–759PubMedCrossRef
34.
Sheehan JP et al (2003) Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98(2):342–349PubMedCrossRef
35.
Amendola BE et al (2000) Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery. Cancer J 6(6):372–376PubMed
36.
Ikushima H et al (2000) Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 48(5):1389–1393PubMedCrossRef
37.
Payne BR et al (2000) Gamma surgery for intracranial metastases from renal cell carcinoma. J Neurosurg 92(5):760–765PubMedCrossRef
38.
Markoe AM, Schwade J (1994) The role for radiation therapy in the management of spine and spinal cord tumors. In: Rea G (ed) Spine tumors. American Association of Neurological Surgeons, Rolling Meadow
39.
Faul CM, Flickinger JC (1995) The use of radiation in the management of spinal metastases. J Neurooncol 23(2):149–161PubMedCrossRef
40.
Lee J et al (2005) A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 104(9):1894–1900PubMedCrossRef
41.
Fossa SD, Kjolseth I, Lund G (1982) Radiotherapy of metastases from renal cancer. Eur Urol 8(6):340–342PubMed
42.
Yamada Y et al (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490PubMedCrossRef
43.
Gerszten PC et al (2005) Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 3(4):288–295PubMedCrossRef
44.
Balagamwala EH, Angelov L, Koyfman SA et al (2012) Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine 17(6):556–564PubMedCrossRef
45.
Sahgal A, Atenafu EG, Chao S et al (2013) Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol 31(27):3426–3431PubMedCrossRef
46.
Verma J, Jonasch E, Allen P, Tannir N, Mahajan A (2011) Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma. Cancer 117(21):4958–4965PubMedCentralPubMedCrossRef
47.
Peeling WB, Mantell BS, Shepheard BG (1969) Post-operative irradiation in the treatment of renal cell carcinoma. Br J Urol 41(1):23–31PubMedCrossRef
  • » This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.
Image Credits